Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Title |
Grant Type |
Focus Area |
Country |
Application Due Date |
---|---|---|---|---|
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
|
Quality Improvement | Oncology | Canada | |
Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
Release Date:
|
Education | Hospital | All | |
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
|
Quality Improvement | Oncology | Canada | |
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
|
Quality Improvement | Rare Disease | All | |
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
|
Research | Rare Disease | Australia, Canada, France, Germany, Italy, Japan, Korea, Spain | |
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
|
Quality Improvement | Oncology | Spain | |
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | Spain | |
2024 IM US Headache Medicine Fellowship
Release Date:
|
Fellowship | Internal Medicine | USA | |
Release Date:
|
Education | Internal Medicine | USA | |
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
|
Education | Vaccines | Japan | |
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
|
Fellowship | Rare Disease | USA |
Title |
Grant Type |
Focus Area |
Country |
Application Due Date |
---|---|---|---|---|
Release Date:
|
||||
Use of PROS in RA
Release Date:
|
||||
Attention-Deficit/Hyperactivity Disorder
Release Date:
|
||||
Symptomatic Vulvovaginal Atrophy in the Postmenopausal Woman
Release Date:
|
||||
Chronic Pain Care Outcomes
Release Date:
|
||||
Chronic Pain Care in the Patient-Centered Medical Home
Release Date:
|
||||
Medication-Overuse Headache (MOH)
Release Date:
|
||||
Reducing Cardiovascular Risk Globally Through Improved Dyslipidemia Awareness and Treatment
Release Date:
|
||||
Community Oncologist Education and Support Systems ‐ Renal Cell Carcinoma and Hematologic Malignancies
Release Date:
|
||||
Disparities in Adult Immunizations
Release Date:
|
||||
Global Bridges Smoking Cessation
Release Date:
|
||||
Advances in Anticoagulation (Pfizer and BMS)
Release Date:
|